Meeting News
September 24, 2018
Using data found on health care claims, researchers developed a machine learning tool that resulted in a “high level of predictive…
Meeting News
September 13, 2018
The risk for abuse was significantly lower among patients using Nucynta extended release than abuse-deterrent formulation opioids and non-abuse…
Meeting News
September 12, 2018
Approximately 16% of patients with migraine who were prescribed triptans overused the medication, according to data presented at PainWeek 2018…
Meeting News
September 7, 2018
A low dose of sumatriptan provided significantly higher 2-hour pain freedom and 2-hour pain relief vs. placebo, according to phase 3 trial findings…
Meeting News
September 6, 2018
Fremanezumab — a fully humanized monoclonal antibody targeting a calcitonin gene-related peptide that researchers said has already demonstrated…
Meeting News
September 5, 2018
A multimodal analgesia approach decreased the amount of opioids prescribed at discharge, adequately controlled pain and reduced hospital length of…
Meeting News
September 22, 2017
Oxycodone DETERx ER, an extended-release, abuse-deterrent drug, safely and effectively managed chronic pain in patients with poorly managed pain…
Meeting News
September 15, 2017
Patients receiving the opioid analgesic NKTR-181 had reduced back pain and exhibited low rates of opioid withdrawal, compared their counterparts who…
Meeting News
September 13, 2017
Compared with placebo, lasmiditan reduced migraine pain and symptoms after 2 hours for most patients with at least moderate disability, according to…
Meeting News
September 8, 2017
In patients with moderate to severe osteoarthritis knee pain, a single intra-articular injection of 1 mg of CNTX-4975 was well tolerated and…